Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
[Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Outcomes of Cognitive-Behavioral Treatment for Insomnia on Insomnia, Depression, and Fatigue for Individuals with Multiple Sclerosis: A Case Series.
Invisible Killers.
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
Improvement of driving skills in persons with Relapsing-Remitting Multiple Sclerosis: a pilot study.
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies.
Hand grip fatigability in persons with multiple sclerosis according to hand dominance and disease progression.
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
Recognizing and overcoming potential barriers to oral medications for MS.
No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
Clinical Relevance of Serum Aquaporin-4 Antibody Levels in Neuromyelitis Optica.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
The multifaceted role of astrocytes in regulating myelination.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection.
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.
PSEUDOBULBAR AFFECT IN MULTIPLE SCLEROSIS PATIENTS.
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.

Pages